Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nonhuman Primate
100%
Protein Scaffold
100%
DNA Vaccine
100%
Dengue Serotypes
100%
Envelope Domain III
100%
Macaque
45%
Post-challenge
45%
Nave
36%
Pregenomic RNA (pgRNA)
36%
Dengue
18%
Dengue Vaccine
18%
Expression Plasmid
18%
Detectable Viremia
18%
Neutralization Titers
18%
Further Development
9%
Protein Components
9%
Rhesus Macaque
9%
Geobacillus Stearothermophilus
9%
Antibody Response
9%
Titer
9%
Intramuscular Injection
9%
Neutralizing Antibodies
9%
Viremia
9%
Correlates of Protection
9%
DNA Expression
9%
Preclinical Development
9%
Dengue Virus
9%
Multimeric
9%
Gene Gun
9%
Virus Vaccine
9%
Tetravalent
9%
E2 Protein
9%
Vaccine Target
9%
Envelope Gene
9%
Protected Animals
9%
Immunology and Microbiology
Macaca
100%
Serotype
100%
Dengue Virus
100%
DNA Immunization
100%
Ribonucleic Acid
80%
Titer
60%
Viremia
60%
Dengue Vaccine
60%
Plasmid
40%
Neutralization
40%
Antibody Response
40%
Dengue Fever
40%
Rhesus Monkey
20%
Geobacillus stearothermophilus
20%
Neutralizing Antibody
20%
Env (Gene)
20%
Preclinical Study
20%
Biochemistry, Genetics and Molecular Biology
Serotype
100%
Scaffold Protein
100%
Dengue Virus
100%
Macaca
83%
RNA
66%
Titer
50%
Viremia
50%
Plasmid
33%
Antibody Response
33%
Rhesus Monkey
16%
Geobacillus stearothermophilus
16%
Primate Model
16%
Preclinical Study
16%
Neutralizing Antibody
16%
Gene Gun
16%
Env (Gene)
16%